Sono TEK (SOTK) Q4 FY26 earnings call: guidance and Q&A

What is the current order activity and segment mix within the backlog, given that prior backlog was heavily clean energy and now is expected to be medical and microelectronics?

The backlog has significantly shifted from clean energy to medical and microelectronics, which are now the fastest-growing sectors. The company's machine integration capabilities developed for clean energy were transferable. Order flow is lumpier due to high ASP platforms ($1M-$3M machines), with a goal to increase the frequency of these large orders.

“I can tell you this current fiscal year, it's very light clean energy related. It's really transitioned and shifted drastically over towards the medical sectors and the microelectronic sectors.”

asked by Richard Ryan · answered by R. Harshbarger

Update on progress in the 300-millimeter wafer market for fabs, following prior discussions about interest from a major semiconductor show.

Progress on 300-millimeter wafers for the fab market is coming along nicely, though taking longer than expected. A new 300-millimeter machine will be introduced at Semicon Europe by calendar year-end. Orders might come in FY27, but actual deliveries are more likely in FY28, as the company is being pulled into this market by customer need.

“We're going to be participating and bringing that $300 million, so of machine is planned for the end of this calendar year to be doing a semiconductor show Semicon in Europe, which is actually the first time we've ever participated in that show for Sono-Tek.”

asked by Richard Ryan · answered by R. Harshbarger

Given the cash buildup and minimal stock repurchases, what is the status of the repurchase program and thoughts on potential M&A?

The stock repurchase program has seen minimal activity (several hundred thousand dollars). The company is actively looking for M&A opportunities but is highly selective, seeking correct valuations and synergies. Cash on hand provides flexibility for strategic moves, and opportunities are more plentiful but higher cost. The company prioritizes organic growth but continues to evaluate buybacks.

“We certainly do continue to have active, both inbound and outbound discussions as part of our normal daily routine in practice at Sono-Tek. We -- like everybody, we're out there looking for the correct valuations and the correct synergies.”

asked by Richard Ryan · answered by R. Harshbarger

Despite a solid backlog, bookings were low, suggesting a slowdown. Is there a pipeline of opportunities to strengthen the second half of FY27, and what markets are driving this?

The backlog is lumpy due to high ASP platforms, which can cause dips and surges. The pipeline is strong, driven by microelectronics and medical sectors. Visibility for the second half of FY27 is challenging because large orders received in the next month could ship this fiscal year, but orders received later might push into the next fiscal year. The company is pushing for larger, more complex platforms.

“Most definitely, though, the big shift, which is going to drive the backlog moving forward, is the ability to drive higher ASP, more complex platforms into the portfolio.”

asked by Edward Jackson · answered by R. Harshbarger

Sono-Tek has consistently delivered strong gross margins but not stellar bottom-line performance. Was this a specific strategy, and what has been accomplished?

The company deliberately reinvested heavily in application engineering, process development, and integrated system capabilities to position for larger, more sophisticated production opportunities. Net margins could have been higher, but near-term profitability was prioritized over growth initiatives. Gross margins remained strong (upper 40s to low 50s) because customers value Sono-Tek's process expertise and integrated solutions, not just equipment.

“I for sure initially expected some downward pressure on margins. But in practicality, that really hasn't happened. We've been able to maintain consistently strong gross margins through that transition.”

asked by Bill Nicklin · answered by R. Harshbarger

Update on the Building 6 expansion, which was previously put on hold, and its potential to increase capacity to $40M-$44M.

The company is proactively expanding manufacturing. The first phase involves a $500k-$600k investment in a mezzanine structure within the existing facility, increasing annual revenue capacity to $35 million. They are working with NY State for support. A second phase, using adjacent leased space, could expand capacity to $45 million. This is driven by broader demand for sophisticated production platforms in medical and microelectronics.

“The investment will likely be in the area and this is early, but $500,000 to $600,000 a and should increase our practical annual revenue capacities to roughly $35 million at this point, it's our latest guess.”

asked by Bill Nicklin · answered by R. Harshbarger

Expressed disappointment in the minimal use of the stock buyback program, especially when the stock was low, as it could boost EPS.

The company acknowledges the question and discusses buybacks at the board level. While they have significant cash, only a minimal amount (several hundred thousand dollars) has been used for buybacks. The cash provides flexibility for strategic M&A opportunities, which are currently more plentiful but higher cost. They will continue to evaluate the timing for buybacks.

“I know we do have a relatively significant amount of cash on hand. And we bought back a relatively small amount of stock to date. It continues to be something we look at closely.”

asked by David McGinnis · answered by R. Harshbarger